BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li C, Lu Y, Cheng L, Zhang X, Yue J, Liu J. Combining Mechanical High-Intensity Focused Ultrasound Ablation with Chemotherapy for Augmentation of Anticancer Immune Responses. Mol Pharm 2021;18:2091-103. [PMID: 33886331 DOI: 10.1021/acs.molpharmaceut.1c00229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Ashar H, Ranjan A. Immunomodulation and targeted drug delivery with high intensity focused ultrasound (HIFU): Principles and mechanisms. Pharmacol Ther 2023;:108393. [PMID: 36965581 DOI: 10.1016/j.pharmthera.2023.108393] [Reference Citation Analysis]
2 Tang J, Tang J, Li H, Zhou J, Tang N, Zhu Q, Wang X, Zhu B, Li N, Liu Z. Mechanical destruction using a minimally invasive Ultrasound Needle induces anti-tumor immune responses and synergizes with the anti-PD-L1 blockade. Cancer Lett 2023;554:216009. [PMID: 36400312 DOI: 10.1016/j.canlet.2022.216009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ning J, Wang S, Guo Y, Diao J, Bai X, Wang H, Hu K, Zhao Q. High Intensity Focused Ultrasound Ablation for Patients With Locally Advanced Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis. J Ultrasound Med 2023. [PMID: 36691925 DOI: 10.1002/jum.16181] [Reference Citation Analysis]
4 Qin Y, Geng X, Sun Y, Zhao Y, Chai W, Wang X, Wang P. Ultrasound nanotheranostics: Toward precision medicine. J Control Release 2023;353:105-24. [PMID: 36400289 DOI: 10.1016/j.jconrel.2022.11.021] [Reference Citation Analysis]
5 Guo HL, Xie XY, Xu M. Application of nanomaterials in combined thermal ablation and immunotherapy for liver tumors. Shijie Huaren Xiaohua Zazhi 2022; 30(19): 829-837 [DOI: 10.11569/wcjd.v30.i19.829] [Reference Citation Analysis]
6 Liu Q, Zhang W, Jiao R, Lv Z, Lin X, Xiao Y, Zhang K. Rational Nanomedicine Design Enhances Clinically Physical Treatment-Inspired or Combined Immunotherapy. Adv Sci (Weinh) 2022;:e2203921. [PMID: 36002305 DOI: 10.1002/advs.202203921] [Reference Citation Analysis]